确立绿藻Chlamydomonas incerta作为重组蛋白质生产的平台
Kalisa Kang1, Évellin do Espirito Santo1,2, Crisandra Jade Diaz1
1Department of Molecular Biology, School of Biological Sciences, University of California San Diego, La Jolla, CA, United States of America.
bioRxiv : the preprint server for biology
|November 1, 2024
概括
克拉米多莫纳斯 incerta显示出产生重组蛋白质的强大潜力,在mCherry表达中表现优于克拉米多莫纳斯 reinhardtii. 这种藻类是生物技术和理解光合作用生物体的一个有前途的平台.
科学领域:
- * 分子生物学 * 分子生物学
- * 生物技术 * 生物技术
- * 藻类研究
背景情况:
- * Chlamydomonas incerta是Chlamydomonas reinhardtii的近亲,正在研究其生物技术应用.
- * 了解光合作用生物体的好处来自对密切相关物种的比较研究.
研究的目的:
- *为了评估 Chlamydomonas incerta 作为重组蛋白表达的宿主.
- * 为了比较其蛋白质生产能力与 Chlamydomonas reinhardtii.
- * 调查蛋白质针对各种细胞区的向.
主要方法:
- * Chlamydomonas incerta的基因转换,具有mCherry,西兰酶和PHL7表达的载体.
- * 对mCherry的光和免疫斑点强度进行比较分析.
- *评估西兰酶分泌和酶活性.
- *评估PHL7在降解聚聚氨中的活性.
- * 探索细胞融合以产生遗传杂交.
主要成果:
- *与C. reinhardtii相比,Clamydomonas incerta表现出明显更高的mCherry光 (3.5倍) 和免疫斑点强度 (3.7倍).
- * 在两种藻类中观察到类似的西兰酶分泌能力和酶活性.
- * 在C. reinhardtii和C. incerta中发现了可比的PHL7活性,用于塑料降解.
- *通过细胞融合成功生成遗传杂交,使基因和标记物交换成为可能.
结论:
- * Chlamydomonas incerta是一种强大的重组蛋白质生产平台,在某些蛋白质上比C. reinhardtii具有优势.
- *这项研究为微藻生物学提供了有价值的见解,并通过混合生成增强了遗传变异.
- * Chlamydomonas incerta对各种生物技术应用具有显著的前景.
更多相关视频
09:11A Comparative Analysis of Recombinant Protein Expression in Different Biofactories: Bacteria, Insect Cells and Plant Systems
Published on: March 23, 2015
23.5K
10:51High-Throughput Robotically Assisted Isolation of Temperature-sensitive Lethal Mutants in Chlamydomonas reinhardtii
Published on: December 5, 2016
9.8K
相关概念视频
Recombinant DNA
104.9K
Overview
104.9K
Upstream Processing
80
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
80
Production of Pharmaceuticals
65
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
65
